↓ Skip to main content

A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative

Overview of attention for article published in JAMA Oncology, May 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news
3 news outlets
policy
1 policy source
twitter
62 X users
facebook
8 Facebook pages
googleplus
3 Google+ users

Citations

dimensions_citation
175 Dimensions

Readers on

mendeley
178 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative
Published in
JAMA Oncology, May 2017
DOI 10.1001/jamaoncol.2016.4851
Pubmed ID
Authors

Wee Loon Ong, Maartje G. Schouwenburg, Annelotte C.M. van Bommel, Caleb Stowell, Kim H. Allison, Karen E. Benn, John P. Browne, Rodney D. Cooter, Geoff P. Delaney, Francois P. Duhoux, Patricia A. Ganz, Patricia Hancock, Reshma Jagsi, Felicia M. Knaul, Anne M. Knip, Linetta B. Koppert, Henry M. Kuerer, Sarah McLaughin, Marc A. M. Mureau, Ann H. Partridge, Dereesa Purtell Reid, Lisa Sheeran, Thomas J. Smith, Mark J. Stoutjesdijk, Marie Jeanne T.F.D. Vrancken Peeters, Yvonne Wengström, Cheng-Har Yip, Christobel Saunders

Abstract

A major challenge in value-based health care is the lack of standardized health outcomes measurements, hindering optimal monitoring and comparison of the quality of health care across different settings globally. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary international working group, comprised of 26 health care providers and patient advocates, to develop a standard set of value-based patient-centered outcomes for breast cancer (BC). The working group convened via 8 teleconferences and completed a follow-up survey after each meeting. A modified 2-round Delphi method was used to achieve consensus on the outcomes and case-mix variables to be included. Patient focus group meetings (8 early or metastatic BC patients) and online anonymized surveys of 1225 multinational BC patients and survivors were also conducted to obtain patients' input. The standard set encompasses survival and cancer control, and disutility of care (eg, acute treatment complications) outcomes, to be collected through administrative data and/or clinical records. A combination of multiple patient-reported outcomes measurement (PROM) tools is recommended to capture long-term degree of health outcomes. Selected case-mix factors were recommended to be collected at baseline. The ICHOM will endeavor to achieve wide buy-in of this set and facilitate its implementation in routine clinical practice in various settings and institutions worldwide.

X Demographics

X Demographics

The data shown below were collected from the profiles of 62 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 178 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 17%
Student > Ph. D. Student 27 15%
Student > Master 18 10%
Other 16 9%
Student > Bachelor 10 6%
Other 27 15%
Unknown 49 28%
Readers by discipline Count As %
Medicine and Dentistry 61 34%
Nursing and Health Professions 15 8%
Economics, Econometrics and Finance 7 4%
Psychology 5 3%
Social Sciences 5 3%
Other 20 11%
Unknown 65 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 63. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2021.
All research outputs
#680,904
of 25,374,647 outputs
Outputs from JAMA Oncology
#1,062
of 3,308 outputs
Outputs of similar age
#13,965
of 324,551 outputs
Outputs of similar age from JAMA Oncology
#26
of 80 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 84.4. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,551 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.